ETFs Similar to PBPH
Comparison Results
| Name | Price | Price Change | Price Target | Smart Score | Expense Ratio | Asset Under Management | Follow |
|---|---|---|---|---|---|---|---|
| CANCTema Oncology ETF | $42.60 | $59.98(40.79% Upside) | 0.75% | 212.82M | |||
| LFSCF/M Emerald Life Sciences Innovation ETF | $44.28 | $64.17(44.92% Upside) | 0.54% | 120.60M | |||
| IBBQInvesco Nasdaq Biotechnology ETF | $35.83 | $45.42(26.75% Upside) | 0.19% | 117.67M | |||
| HRTSTema Cardiovascular and Metabolic ETF | $37.74 | $44.76(18.60% Upside) | 0.75% | 55.62M | |||
| OZEMRoundhill GLP-1 & Weight Loss ETF | $29.75 | $46.28(55.58% Upside) | 0.59% | 53.85M | |||
| PSILAdvisorShares Psychedelics ETF | $21.45 | $53.65(150.11% Upside) | 1.00% | 45.56M | |||
| IBRNiShares Neuroscience and Healthcare ETF | $32.92 | $53.93(63.81% Upside) | 0.47% | 6.45M | |||
| THNRAmplify Weight Loss Drug & Treatment ETF | $24.72 | $34.23(38.48% Upside) | 0.59% | 5.66M | |||
| BIBProShares Ultra Nasdaq Biotechnology | $118.56 | ― | 0.95% | 95.56M | |||
| BISProShares UltraShort Nasdaq Biotechnology | $10.65 | ― | 0.95% | 1.89M |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CANC | Tema Oncology ETF | 42.60 | 11.98 | 39.12% | |
| LFSC | F/M Emerald Life Sciences Innovation ETF | 44.28 | 12.60 | 39.78% | |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 35.83 | 9.92 | 38.27% | |
| HRTS | Tema Cardiovascular and Metabolic ETF | 37.74 | 5.85 | 18.36% | |
| OZEM | Roundhill GLP-1 & Weight Loss ETF | 29.75 | 2.44 | 8.92% | |
| PSIL | AdvisorShares Psychedelics ETF | 21.45 | 3.18 | 17.41% | |
| IBRN | iShares Neuroscience and Healthcare ETF | 32.92 | 2.99 | 9.98% | |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 24.72 | 2.14 | 9.50% | |
| BIB | ProShares Ultra Nasdaq Biotechnology | 118.56 | 49.87 | 72.61% | |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 10.65 | -11.02 | -50.86% |
ETFs Similar to PBPH FAQ
What is the cheapest alternative to PBPH?
None of the similar ETFs listed here costs less than PBPH, whose expense ratio is 0.13% a year. The lowest-cost alternative is IBBQ (Invesco Nasdaq Biotechnology ETF), at 0.19%.
PBPH vs. CANC: what is the difference?
CANC (Tema Oncology ETF) is the first ETF in PBPH's similar-ETF list. It has $212.82M in assets under management and a 0.75% expense ratio, against $1.12B and 0.13% for PBPH. Compare their performance, price targets and Smart Scores in the table above.